Abstract:Objectives In the present study, we investigated underlying mechanisms for the effects caused by pioglitazone, a peroxisomeproliferator-activated receptor (PPAR)-γ activator, on atrial structural remodelling and electrical remodelling in alloxan-induced diabetic rabbits. Methods 32 rabbits were randomly divided into four groups: normal control group (CN group), diabetic group (DM group), diabetic pioglitazone treatment A group (DPG group, 4 mg/day/kg) and diabetic pioglitazone treatment B group (DPI group, 8 mg/day/kg). All rabbits were monitored hemodynamics and recorded aortic systolic and diastolic blood pressure (SBP and DBP) and left ventricle end diastolic pressure (LVEDP) and underwent transthoracic echocardiographic examination. After 8-week treatment, whole-cell patch-clamp technique was used to measure action potential duration (APD) and atrial ionic currents (ICaL and INa). Isolated Langendorff perfused rabbit hearts were used to evaluate atrial electrophysiological parameters. Atrial collagen volume fraction (CVF) was calculated by Sirius-Red (SR) staining for pathological examination. Western-blot was applied to assess atrial protein expression levels of NF-κB p50/p65, TGF-β, HSP70, ERK1/2 and p-ERK1/2. Results Echocardiographic examination showed that LAD, IVST and PWT of DPG and DPI group were significantly decreased compared with DM group. SBP and DBP of DPI group were significantly lower than DM group (p<0.05). No significant difference of LVEDP was among the four groups (p>0.05). Histopathological examination revealed that left atrialmyocytes disordered accompanied by inflammatory cells infiltration and a large amount of interstitialfibrosis distributed throughout the tissue in DM group. SR staining showed that left atrium collagen volume fraction (LACVF) was significantly increased in DM group (p<0.01). But these pathological abnormal findings were attenuated in DPG and DPI group. Compared with CN group, IACT was prolonged (p<0.01), AERPD was increased (p<0.01) in DM group. Inducibility of AF in DM group was significantlyhigher than controls (6/8 vs 1/8 of animals, p<0.01). Inducibility of AF in DPI group was significantly less than DM group (2/8 vs 6/8 of animals, p<0.01). Prolonged IACT, AERPD, AF episode and enhanced inducibility of AF were attenuated in DPG and DPI group. APD90 andAPD50 of left atrial myocyte were prolonged in DM group (p<0.05 vs control), and APD90 rate adaptation was no significant differences (p>0.05 vs control). The densities of INa were reduced and the densities of ICaL were increased in DM group (p<0.01 vs control), which were attenuated in DPG and DPI group. TGF-β, NF-κB p50/p65, HSP70, ERK1/2, p-ERK1/2 were increased significantly in DM (p<0.05 s. control). Protein expression of ERK1/2 was no significant difference between DPG or DPI group and DM group (p>0.05), but protein expressions of NF-κB p50/p65, HSP70, TGF-β andp-ERK1/2 were significantly decreased in DPG and DPI group (p<0.05), but no significant differences between two pioglitazone groups. Conclusions Pioglitazone inhibited DM-related arrhythmogenic atrial remodelling and vulnerability to AF. Pioglitazone may play important preventions from AF in diabetes. PPAR-γ activators could become novel upstream therapy drugs for DM-related AF.

Glycyrrhetinic acid alleviates atrial fibrillation by inhibiting the expression of PIM1

Gallic Acid Ameliorates Angiotensin II-Induced Atrial Fibrillation by Inhibiting Immunoproteasome- Mediated PTEN Degradation in Mice

Inhibitory Effects of Propylene Glycol Alginate Sodium Sulfate Derivatives on Atrial Fibrosis in Atrial Fibrillation

Quercetin improves atrial fibrillation through inhibiting TGF-β/Smads pathway via promoting MiR-135b expression

Arnebiae Radix Prevents Atrial Fibrillation in Rats by Ameliorating Atrial Remodeling and Cardiac Function

The expression profile analysis of atrial mRNA in rats with atrial fibrillation: the role of IGF1 in atrial fibrosis

Intermedin 1-53 Ameliorates Atrial Fibrosis and Reduces Inducibility of Atrial Fibrillation via TGF-β1/pSmad3 and Nox4 Pathway in a Rat Model of Heart Failure

Gallic Acid Increases Atrial Natriuretic Peptide Secretion and Mechanical Dynamics Through Activation of PKC.

Paeoniflorin Inhibits Atrial Fibrosis and Atrial Fibrillation in Angiotensin II-Infused Mice Through the PI3K-Akt Pathway

Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models

Original Article Therapeutic Effects Of Panax Notoginseng Saponins Against Atrial Fibrillation In Rats

Prostaglandin I2 signaling prevents angiotensin II-induced atrial remodeling and vulnerability to atrial fibrillation in mice

Pioglitazone Alleviates Β1-Adrenergic Receptor Antibody-Induced Atrial Fibrillation Susceptivity Via Mitigation of PPAR-γ-Mediated Metabolic Inflexibility.

Pioglitazone Prevents Diabetes-Related Atrial Fibrillation Susceptibility in Alloxan-Induced Diabetic Rabbits

Glycyrrhizic acid attenuates myocardial injury: Involvement of RIP140/NF-kB Pathway

Halofuginone ameliorates the susceptibility to atrial fibrillation by activating the PI3K/Akt signaling pathway

O137 Pioglitazone Attenuates Atrial Remodeling and Vulnerability to Atrial Fibrillation in Alloxan-Induced Diabetic Rabbits

Glycyrrhizic acid alleviated MI/R-induced injuries by inhibiting Hippo/YAP signaling pathways

CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post‐Myocardial Infarction Rats

Glycyrrhizic acid ameliorates hepatic fibrosis by inhibiting oxidative stress via AKR7A2

Study of the atrial fibrosis and the expression of PDGF receptor-β during atrial fibrillation